Gencellmed Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Series B
- (Cancelled)
- Investors
-
9
Gencellmed General Information
Description
Developer of an anti-cancer drug treatment platform intended to develop next-generation immune-enhancing anti-cancer herpes virus (oHSV-1) drugs. The company specializes in developing the next-generation new drug against herpesviruses (oHSV-1) with dual action to stimulate the infectious power of cancer cells and the body's immune response, providing medical professionals with drugs to cure cancer.
Contact Information
Website
www.gencellmed.comCorporate Office
- Room 302, Research Building Number 3, 75 Nowon-ro
- Gongneung-dong, Korea Institute of Radiology, Nowon-gu
- Seoul, 01812
- South Korea
Corporate Office
- Room 302, Research Building Number 3, 75 Nowon-ro
- Gongneung-dong, Korea Institute of Radiology, Nowon-gu
- Seoul, 01812
- South Korea
Gencellmed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 24-Jul-2025 | Cancelled | Pre-Clinical Trials | |||
| 4. Later Stage VC | 16-Jul-2025 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC (Series A) | 01-Apr-2021 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 01-Oct-2019 | Completed | Pre-Clinical Trials | |||
| 1. Seed Round | 30-Sep-2019 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Gencellmed Comparisons
Industry
Financing
Details
Gencellmed Competitors (2)
One of Gencellmed’s 2 competitors is Amgen, a Formerly PE-Backed company based in Thousand Oaks, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Amgen | Formerly PE-Backed | Thousand Oaks, CA | ||||
| Daiichi Sankyo | Corporation | Tokyo, Japan |
Gencellmed Patents
Gencellmed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021287536-A1 | Multi-targeting recombinant herpes simplex viruses and use thereof | Active | 12-Jun-2020 | ||
| AU-2021287536-B2 | Multi-targeting recombinant herpes simplex viruses and use thereof | Active | 12-Jun-2020 | ||
| CA-3181143-A1 | Multi-targeting recombinant herpes simplex viruses and use thereof | Pending | 12-Jun-2020 | ||
| EP-4166656-A1 | Multi-targeting recombinant herpes simplex viruses and use thereof | Pending | 12-Jun-2020 | ||
| EP-4166656-A4 | Multi-targeting recombinant herpes simplex viruses and use thereof | Pending | 12-Jun-2020 | A61K35/763 |
Gencellmed Signals
Gencellmed Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Korean Venture Capital Association | Venture Capital | Minority | ||
| DAYLI Partners | Venture Capital | Minority | ||
| Innopolis Partners | Venture Capital | Minority | ||
| KDB Capital | PE/Buyout | Minority | ||
| Lighthouse Combined Investment | Venture Capital | Minority |
Gencellmed FAQs
-
When was Gencellmed founded?
Gencellmed was founded in 2019.
-
Where is Gencellmed headquartered?
Gencellmed is headquartered in Seoul, South Korea.
-
What is the size of Gencellmed?
Gencellmed has 9 total employees.
-
What industry is Gencellmed in?
Gencellmed’s primary industry is Drug Discovery.
-
Is Gencellmed a private or public company?
Gencellmed is a Private company.
-
What is Gencellmed’s current revenue?
The current revenue for Gencellmed is .
-
How much funding has Gencellmed raised over time?
Gencellmed has raised $5.81M.
-
Who are Gencellmed’s investors?
Korean Venture Capital Association, DAYLI Partners, Innopolis Partners, KDB Capital, and Lighthouse Combined Investment are 5 of 9 investors who have invested in Gencellmed.
-
Who are Gencellmed’s competitors?
Amgen and Daiichi Sankyo are competitors of Gencellmed.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process